|
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
A - A |
239,703 |
0.00 |
0.00 |
239,703 |
|
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
D - D |
473,334 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
A - A |
473,334 |
0.00 |
0.00 |
473,334 |
|
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
D - D |
135,134 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
A - A |
135,134 |
0.00 |
0.00 |
135,134 |
|
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
D - D |
50,041 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
A - A |
50,041 |
0.00 |
0.00 |
50,041 |
|
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
D - D |
100,000 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
A - A |
100,000 |
0.00 |
0.00 |
100,000 |
|
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
D - D |
150,000 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
A - A |
150,000 |
0.00 |
0.00 |
150,000 |
|
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
D - D |
350,000 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
A - A |
350,000 |
0.00 |
0.00 |
350,000 |
|
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
D - D |
700,000 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Russo Rene |
|
2025-11-21 |
A - A |
700,000 |
0.00 |
0.00 |
700,000 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
925,000 |
0.00 |
0.00 |
925,000 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
155,090 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - D |
155,090 |
0.00 |
0.00 |
155,090 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
23,786 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
23,786 |
0.00 |
0.00 |
23,786 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
37,296 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
37,296 |
0.00 |
0.00 |
37,296 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
45,000 |
0.00 |
0.00 |
0 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
A - A |
45,000 |
0.00 |
0.00 |
45,000 |
|
Xilio Therapeutics, Inc. |
Frankenfield Christopher James |
|
2025-11-21 |
D - D |
20,000 |
0.00 |
0.00 |
0 |